- Home
- IMMP vs HRZN Comparison
IMMP vs HRZN Comparison
Compare IMMP & HRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMMP
- HRZN
- Stock Information
- Founded
- IMMP 1987
- HRZN 2008
- Country
- IMMP Australia
- HRZN United States
- Employees
- IMMP N/A
- HRZN N/A
- Industry
- IMMP Biotechnology: Pharmaceutical Preparations
- HRZN Finance/Investors Services
- Sector
- IMMP Health Care
- HRZN Finance
- Exchange
- IMMP Nasdaq
- HRZN Nasdaq
- Market Cap
- IMMP 251.8M
- HRZN 295.3M
- IPO Year
- IMMP N/A
- HRZN 2010
- Fundamental
- Price
- IMMP $1.64
- HRZN $6.85
- Analyst Decision
- IMMP Buy
- HRZN Hold
- Analyst Count
- IMMP 1
- HRZN 4
- Target Price
- IMMP $7.00
- HRZN $7.81
- AVG Volume (30 Days)
- IMMP 87.8K
- HRZN 624.6K
- Earning Date
- IMMP 10-21-2025
- HRZN 10-28-2025
- Dividend Yield
- IMMP N/A
- HRZN 19.27%
- EPS Growth
- IMMP N/A
- HRZN N/A
- EPS
- IMMP N/A
- HRZN N/A
- Revenue
- IMMP $3,306,742.00
- HRZN $97,144,000.00
- Revenue This Year
- IMMP N/A
- HRZN $0.51
- Revenue Next Year
- IMMP $725.37
- HRZN $9.90
- P/E Ratio
- IMMP N/A
- HRZN N/A
- Revenue Growth
- IMMP 31.28
- HRZN N/A
- 52 Week Low
- IMMP $1.32
- HRZN $6.77
- 52 Week High
- IMMP $2.71
- HRZN $11.08
- Technical
- Relative Strength Index (RSI)
- IMMP 46.06
- HRZN 36.98
- Support Level
- IMMP $1.60
- HRZN $6.79
- Resistance Level
- IMMP $1.68
- HRZN $7.07
- Average True Range (ATR)
- IMMP 0.07
- HRZN 0.11
- MACD
- IMMP -0.00
- HRZN 0.03
- Stochastic Oscillator
- IMMP 28.12
- HRZN 21.43
About IMMP Immutep Limited
Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.
About HRZN Horizon Technology Finance Corporation
Horizon Technology Finance Corp is a specialty finance company. Its investment objective is to maximize its investment portfolio's total return by generating current income from the debt investments it makes and capital appreciation from the warrants it receives when making such debt investments. It lends to and invests in development-stage companies in the technology, life science, healthcare information and services, and sustainability industries.